Chromatographic, ultracentrifugal, and related studies of fibrinogen "Baltimore".
Chromatographic, ultracentrifugal, and related studies of the fibrinogen of a patient with a congenital disorder of fibrinogen (fibrinogen "Baltimore" have provided evidence of structural differences from normal.Diethylaminoethyl-cellulose (DEAE-cellulose) gradient elution chromatography demonstrated two major peaks in the elution pattern of fibrinogen Baltimore as was the case for normal fibrinogen. However, the first peak of fibrinogen Baltimore was somewhat broader and more symmetrical and was eluted significantly later in the chromatogram than the corresponding peak of normal fibrinogen. Additionally, in some elution patterns, a shoulder on the ascending limb of peak 1 was present, suggesting the presence of chromatographically "normal" fibrinogen. Thrombin time determinations of eluted column fractions from a chromatogram of propositus fibrinogen supported this conclusion by demonstrating that fibrinogen from the ascending portion of peak 1 behaved functionally more like normal than that later in the chromatogram. Chromatograms of mixtures of propositus and normal fibrinogen confirmed the ability of this technique to distinguish normal from Baltimore fibrinogen. Chromatograms of fibrinogen isolated from two affected daughters displayed the characteristic increased anionic binding of peak 1 fibrinogen. Sedimentation velocity experiments indicated that the S(o) (20, [unk]) of fibrinogen Baltimore was slightly greater (8.13S vs. 7.85S) than that of normal fraction I-4. Differences in concentration dependence (- 0.65 c vs. - 1.30 c for normal) of the sedimentation coefficient could be attributable in part to spatial conformational differences. Molecular sieving experiments in acrylamide gels indicated that the molecular weight of propositus fraction I-2 was about the same as that of normal fibrinogen of comparable solubility (i.e. I-4, mol wt 325,000). Studies of the UV spectra, tyrosine/tryptophan ratios, sialic acid and hexose content, and N-terminal amino acids demonstrated no consistent significant differences from normal fraction I-4.
D000596:Amino Acids / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000151:congenital*; D002845:Chromatography; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006601:Hexoses / Q000032:analysis; D006801:Humans; D009438:Neuraminic Acids / Q000032:analysis; D011517:Prothrombin Time; D013053:Spectrophotometry; D014461:Ultracentrifugation
D000596:Amino Acids; D006601:Hexoses; D009438:Neuraminic Acids; D005340:Fibrinogen
Fed Proc. 1965 Jul-Aug;24(4):816-21
5829185
Nature. 1965 Oct 9;208(5006):143-5
4956920
Br J Haematol. 1966 Nov;12(6):667-77
5927094
Biochemistry. 1966 Sep;5(9):2829-35
5961868
Biochemistry. 1967 Oct;6(10):3279-87
6056988
Nature. 1968 Apr 13;218(5137):134-7
5645286
Schweiz Med Wochenschr. 1966 Sep 17;96(37):1196-9
5996847
J Lab Clin Med. 1968 Sep;72(3):455-72
5674077
J Clin Invest. 1969 Feb;48(2):235-49
4974308
Br J Haematol. 1969 Apr;16(4):353-61
5306202
J Lab Clin Med. 1951 Feb;37(2):316-20
14814359
Arch Biochem Biophys. 1951 Jul;32(2):317-24
14857750
Methods Biochem Anal. 1955;2:279-311
14393571
Methods Biochem Anal. 1955;2:359-425
14393573
Helv Paediatr Acta. 1958 Oct;13(4):380-99
13610256
J Biol Chem. 1959 Aug;234(8):1971-5
13672998
Can Med Assoc J. 1963 Jan 5;88:19-22
13960907
Proc Soc Exp Biol Med. 1963 Aug-Sep;113:989-94
14073163
Biochim Biophys Acta. 1965 Jan 4;97:171-3
14284312
Immunology. 1960 Jan;3:95-106
13792817